Uganda vs United States of America: Treatment success rate for patients treated for MDR-TB
Uganda
89.0%
in 2022
United States of America
87.0%
in 2021
Uganda rank
25th
United States of America rank
27th
Treatment success rate for patients treated for MDR-TB over time
- Uganda
- United States of America
How they compare
Uganda currently reports 89.0% against 87.0% in United States of America, a difference of 2.0%.
The two have swapped places 6 times across 14 shared years of data; in 2008 it was Uganda ahead.
Uganda ranks 25th and United States of America ranks 27th of 163 countries.
Uganda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Uganda | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 87.5% | 65.0% | 22.5% | Uganda |
| 2010s | 76.1% | 74.9% | 1.2% | Uganda |
| 2020s | 87.5% | 83.5% | 4.0% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Uganda or United States of America?
- Uganda, at 89.0% against 87.0% in United States of America as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Uganda and United States of America?
- 2.0%, with Uganda ahead.
- How many years of comparable data are there for Uganda and United States of America?
- 14 years are reported by both, from 2008 to 2021.
- How do Uganda and United States of America rank globally for treatment success rate for patients treated for mdr-tb?
- Uganda ranks 25th and United States of America ranks 27th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.